Health, Medical & Pharma News - Updated Daily page 61

Positive Top-line Results from Phase 3 Study of Effexor in Japanese Adults with Generalized Anxiety Disorder

PITTSBURGH and TOKYO, Oct. 9, 2024. Viatris Inc., a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japa

Antidepressant Warnings Had Unintended Impact on Youth Mental Health

Youth antidepressant warnings had a detrimental unintended effect significant reductions in mental health care, according to a report published in the October i

Cancer Incidence Increased for People With Multiple Sclerosis

Cancer incidence is increased overall in people with multiple sclerosis (PwMS), with considerable differences depending on cancer type, age, and sex, according

Age-Related Macular Degeneration Tied to Heightened Risk for Rheumatoid Arthritis

Age-related macular degeneration (AMD) is associated with a higher risk for rheumatoid arthritis (RA), according to a study published online Sept. 9 in Scientif

Risk for Second Melanoma Up for Those With First Melanoma Diagnosis

Patients with a first melanoma diagnosis have an increased risk for a second melanoma diagnosis, regardless of race and ethnicity, according to a research lette

Common Acne Drug, Benzoyl Peroxide, Might Become Carcinogenic at Room Temperature

Widely-used acne creams can become contaminated with a known carcinogen even if kept at room temperature, a new study warns. Creams containing benzoyl peroxide

Steady Rise in U.S. Cases of Tick-Borne Babesiosis Disease

Cases of a tick-borne parasitic disease have steadily increased in recent years, a new study shows. Rates of babesiosis increased an average 9 a year in the Uni

Affordable Care Act Is Helping Young Americans With Cancer Beat the Disease

Cancer in young adults is rare, but the insurance coverage given them by the Affordable Care Act (ACA) has greatly boosted the survival of people ages 19 to 25

Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds, Wegovy, Zepbound, for Employees

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health

Online Tool Enhances Decision-Making for Timing of Breast Reconstruction

An online decision aid is helpful for breast cancer patients deciding about immediate breast reconstruction (BR) after mastectomy, according to a study publishe

Pharmaceutical News and Articles